Effect of Bifidobacterium Lactis HN019 on Colonic Transit Time and Digestive Symptoms
Launched by FONTERRA RESEARCH CENTRE · Jul 27, 2010
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • healthy males and females aged 25 to 65 years
- • stool type 2-4 on the Bristol Stool Chart
- • 1 to 3 bowel movements per week
- Exclusion Criteria:
- • use of any probiotic product intended to improve gastrointestinal function within the 2 weeks preceding study entry
- • major chronic and uncontrolled systemic medical conditions
- • severe gastrointestinal conditions known to prolong CTT
- • lactose intolerance
- • chronic diarrhea
- • gastric bypass surgery or lap band insertion for weight loss
- • regular laxative use
- • pregnant or breast-feeding women
About Fonterra Research Centre
Fonterra Research Centre is a leading organization dedicated to advancing dairy science and innovation. As a key arm of Fonterra Co-operative Group, one of the world’s largest exporters of dairy products, the research center focuses on pioneering research and development initiatives that enhance the quality, safety, and sustainability of dairy production. With a multidisciplinary team of experts, Fonterra Research Centre conducts cutting-edge clinical trials and studies aimed at unlocking the nutritional and health benefits of dairy, while also exploring new technologies and processes to optimize production efficiency. Committed to scientific excellence and collaboration, the center plays a vital role in driving the future of the dairy industry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Philip Waller, MD
Principal Investigator
Accurate Clinical Research, Houston, TX
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials